Ginger Joint Pain Meta-analysis: What the Evidence Says
Ginger Joint Pain Meta-analysis has 2 source documents in the current Migaku evidence database. The strongest available sources in this first pass are systema
Quick Answer
Ginger Joint Pain Meta analysis has 2 source documents in the current Migaku evidence database. The strongest available sources in this first pass are systematic review, so conclusions should be framed as evidence aware guidance rather than medical advice.
Key Takeaways
- 01This page is generated only from sources stored in the Migaku evidence knowledge base.
- 02Current evidence mix: 1 systematic review, 1 narrative review.
- 03Claims should be interpreted with the source type, study design, population, and publication date in mind.
- 04This article is educational and does not replace care from a qualified clinician.
Ginger Joint Pain Meta-analysis: What the Evidence Says
Quick Answer
Ginger Joint Pain Meta-analysis has 2 source documents in the current Migaku evidence database. The strongest available sources in this first pass are systematic review, so conclusions should be framed as evidence-aware guidance rather than medical advice.
Key Takeaways
- This page is generated only from sources stored in the Migaku evidence knowledge base.
- Current evidence mix: 1 systematic review, 1 narrative review.
- Claims should be interpreted with the source type, study design, population, and publication date in mind.
- This article is educational and does not replace care from a qualified clinician.
Evidence Map
| Source | Evidence type | Level | Date | Identifier |
|---|---|---|---|---|
| Comparative Effectiveness of Nutritional Supplements in the Treatment of Knee Osteoarthritis: A Network Meta-Analysis | systematic review | 1 | 2025-08-03 | 10.3390/nu17152547 |
| Ginger Bioactives as Multi-Target Therapeutics: Mechanisms, Delivery Innovation, and Human Health Impact | narrative review | 3 | 2026-03-27 | 10.3390/nu18071079 |
What The Sources Report
- However, prolonged NSAID use is associated with various adverse effects, including gastrointestinal complications, cardiovascular disease, and potential renal and hepatic toxicity. [Zhang Yuntong (2025); evidence level 1]
- As a result, many patients with KOA seek alternative or non-pharmacological therapies to relieve pain and functional impairment. [Zhang Yuntong (2025); evidence level 1]
- Zingiber officinale 1 2 3 4 5 Ginger (Roscoe) is a perennial herb belonging to the Zingiberaceae family and is predominantly found in Southeast Asia. [Simeone Pasquale (2026); evidence level 3]
- The precise geographic origin of ginger remains uncertain; however, historical evidence suggests that it was first cultivated in China and neighboring regions of Southeast Asia. [Simeone Pasquale (2026); evidence level 3]
How To Read This Evidence
Evidence level 1 generally reflects systematic reviews or meta-analyses. Level 2 includes randomized trials, guidelines, or public-health guidance. Level 3 usually reflects observational or narrative-review evidence. Level 4 is weaker or early-stage evidence. The level is a sorting aid, not a final quality grade.
Practical Interpretation
There is at least one systematic-review style source in the current set, so it deserves more weight than single-study evidence. For ginger joint pain meta-analysis, the next editorial step is to add more targeted sources and separate strong findings from early or indirect evidence.
Limits Of This First Pass
This is a small-batch MVP article. It uses the first ingested sources for this topic and should be expanded with more targeted searches, license review, and human editorial checks before being treated as a definitive review.
References
- Zhang Yuntong (2025). Comparative Effectiveness of Nutritional Supplements in the Treatment of Knee Osteoarthritis: A Network Meta-Analysis. DOI: 10.3390/nu17152547. PMCID: PMC12348802. PMID: 40806131. License: CC BY 4.0. https://pmc.ncbi.nlm.nih.gov/articles/PMC12348802/
- Simeone Pasquale (2026). Ginger Bioactives as Multi-Target Therapeutics: Mechanisms, Delivery Innovation, and Human Health Impact. DOI: 10.3390/nu18071079. PMCID: PMC13074413. PMID: 41978129. License: CC BY 4.0. https://pmc.ncbi.nlm.nih.gov/articles/PMC13074413/
Safety Note
Health information can change, and individual risk depends on medical history, medications, pregnancy status, age, and diagnosis. Talk with a qualified clinician before changing treatment, supplement, or medication routines.
FAQ
Frequently Asked Questions
Medically reviewed
Last reviewed August 10, 2026 by Migaku Evidence Review
